Can the assessment of ABCB1 gene expression predict its function in vitro?

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• ABCB1 gene expression is linked to multidrug resistance (MDR) and poor cancer prognosis.
• Clinical validation of ABCB1's role in MDR is challenging due to assay limitations.
• P-glycoprotein (P-gp) mediated resistance involves complex mechanisms beyond simple expression levels.

Purpose of the Study:

• To evaluate the predictive accuracy of common ABCB1 expression detection methods for its functional activity in drug resistance.
• To investigate the correlation between ABCB1 mRNA and protein levels and P-gp functional activity in vitro.
• To assess the reliability of quantitative real-time polymerase chain reaction (qRT-PCR) and flow cytometry in predicting drug resistance.

Main Methods:

• ABCB1 mRNA levels were quantified using quantitative real-time polymerase chain reaction (qRT-PCR).
• ABCB1 protein expression was assessed by flow cytometry using the UIC2 antibody.
• Functional P-gp activity was determined using a calcein AM accumulation assay.

Main Results:

• K562 cells showed significantly higher ABCB1 mRNA levels than HL-60 cells, but without detectable P-gp function.
• Resistant K562/Dox cells had higher ABCB1 mRNA expression than K562/HHT cells, yet functional tests showed opposing results.
• Flow cytometry assessment of P-gp expression contradicted functional assays in multiple multidrug-resistant cell lines.

Conclusions:

• Simple correlations between ABCB1 expression (mRNA or protein) and overall drug resistance may be unreliable for predicting P-gp's contribution.
• Expression data for ABCB1 only roughly reflects transporter function, even under controlled in vitro conditions.
• Functional assays are crucial for accurately assessing P-gp's role in multidrug resistance.